Gocovri Capsule, Coated Pellets
Product Images NDC 17772-085

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Gocovri (NDC 17772-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Supernus Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gocovri 01)

Chemical structure of amantadine hydrochloride, showing the adamantane cage with an amino group and a hydrochloride component.*

FDA Label Image

Principal Display Panel (68.5 mg Capsule Bottle Label)

Label for GOCOVRI 68.5 mg extended release capsules containing amantadine, manufactured for Adamas Operations, LLC. The package contains 60 capsules. The label includes storage instructions, dosage strength, NDC 17772-085-60, and a note to see the full prescribing information on the package insert.*

FDA Label Image

Principal Display Panel (137 mg Capsule Bottle Label)

Label for GOCOVRI extended release capsules containing 137 mg of amantadine. The label indicates 60 capsules per package, manufactured for Adamas Operations, LLC, Emeryville, CA. It includes storage instructions, a barcode, and states the drug is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.